Acute and Critical Care

Case Reports

Cardiology
Acute perimyocarditis mimicking acute myocardial infarction in a 12-year-old boy with duchenne muscular dystrophy: Ho Jung Choi, Hye Won Kwon, Kyung Jin Oh, Mi Kyoung Song; Acute Crit Care. 2022;37(2):258-262. Published online November 16, 2021; DOI: https://doi.org/10.4266/acc.2021.00290

4,923 View
250 Download
3 Web of Science
3 Crossref

Differential diagnosis of chest pain in the pediatric population is important but can be challenging. A 12-year-old boy with Duchenne muscular dystrophy presented with chest pain, cardiac enzyme elevation, and convex ST elevations in the inferior leads with reciprocal ST depression in the anterior leads on electrocardiogram. Echocardiography on admission revealed normal left ventricular function. Suspecting acute myocardial infarction, we performed invasive coronary angiography, which revealed normal coronary arteries. A follow-up electrocardiogram showed an acute pericarditis pattern with concave ST elevations in most leads and PR depression, and follow-up echocardiography revealed global left ventricular dysfunction, suggestive of acute perimyocarditis. Ibuprofen was administered for acute pericarditis, and a continuous milrinone infusion was commenced for myocardial dysfunction. The chest pain improved by the next day, and the ST segment elevations normalized on day 4. Echocardiography on day 9 revealed improved left ventricular function. The patient was discharged on day 11, and he is doing well without chest pain through 12 months of follow-up. The last electrocardiogram showed normal sinus rhythm without ST change. Differential diagnosis of acute myocardial infarction and acute perimyocarditis is important for proper treatment strategies and the different prognoses of these two conditions.

Citations

Citations to this article as recorded by

Pediatric Chest Pain: A Review of Diagnostic Tools in the Pediatric Emergency Department
Szu-Wei Huang, Ying-Kuo Liu
Diagnostics.2024; 14(5): 526. CrossRef
Successful treatment of acute myocardial injury of Duchenne muscular dystrophy with steroids: a case report
Merve Oğuz, Dolunay Gürses, Furkan Ufuk, Münevver Yılmaz, Olcay Güngör
Journal of Cardiothoracic Surgery.2023;[Epub] CrossRef
Comprehensive cardiac magnetic resonance T1, T2, and extracellular volume mapping to define Duchenne cardiomyopathy
Sudeep D. Sunthankar, Kristen George-Durrett, Kimberly Crum, James C. Slaughter, Jennifer Kasten, Frank J. Raucci, Larry W. Markham, Jonathan H. Soslow
Journal of Cardiovascular Magnetic Resonance.2023; 25(1): 44. CrossRef

Cardiology
Acute fulminant myocarditis following influenza vaccination requiring extracorporeal membrane oxygenation: Youn-Jung Kim, Jun-Il Bae, Seung Mok Ryoo, Won Young Kim; Acute Crit Care. 2019;34(2):165-169. Published online November 7, 2018; DOI: https://doi.org/10.4266/acc.2017.00045

10,346 View
194 Download
24 Web of Science
26 Crossref

Abstract PDF

The inactivated influenza vaccination is generally safe with mostly mild side effects. We report a rare but fatal adverse event following influenza vaccination. A previously healthy 27-yearold woman who received the influenza vaccination 3 days before presenting to the emergency department had rapidly aggravating dyspnea and mental deterioration. She was diagnosed as having acute fulminant myocarditis with refractory cardiogenic shock, which was successfully managed with veno-arterial extracorporeal membrane oxygenation. The cardiac function of the patient recovered in 3 weeks.

Citations

Citations to this article as recorded by

Active surveillance for adverse events of influenza vaccine safety in elderly cancer patients using self-controlled tree-temporal scan statistic analysis
Na-Young Jeong, Chung-Jong Kim, Sang Min Park, Ye-Jee Kim, Joongyub Lee, Nam-Kyong Choi
Scientific Reports.2023;[Epub] CrossRef
The Incidence of Myocarditis Following an Influenza Vaccination: A Population-Based Observational Study
Wen-Hwa Wang, Kai-Che Wei, Yu-Tung Huang, Kuang-Hua Huang, Tung-Han Tsai, Yu-Chia Chang
Drugs & Aging.2023; 40(2): 145. CrossRef
Comparison of COVID-19 Vaccine-Associated Myocarditis and Viral Myocarditis Pathology
Kamron Reza Hamedi, Gannett Loftus, Lawson Traylor, Richard Goodwin, Sergio Arce
Vaccines.2023; 11(2): 362. CrossRef
Myocarditis and autoimmunity
Akira Matsumori
Expert Review of Cardiovascular Therapy.2023; 21(6): 437. CrossRef
Cardiovascular magnetic resonance (CMR) and positron emission tomography (PET) imaging in the diagnosis and follow-up of patients with acute myocarditis and chronic inflammatory cardiomyopathy
Federico Caobelli, Jordi Broncano Cabrero, Nicola Galea, Philip Haaf, Christian Loewe, Julian A. Luetkens, Giuseppe Muscogiuri, Marco Francone
The International Journal of Cardiovascular Imaging.2023; 39(11): 2221. CrossRef
Clinical Syndromes Related to SARS-CoV-2 Infection and Vaccination in Pediatric Age: A Narrative Review
Maria Vincenza Mastrolia, Camilla De Cillia, Michela Orlandi, Sarah Abu-Rumeileh, Ilaria Maccora, Valerio Maniscalco, Edoardo Marrani, Ilaria Pagnini, Gabriele Simonini
Medicina.2023; 59(11): 2027. CrossRef
Acute Lymphocyte Myocarditis Associated with Influenza Vaccination
Ryo Nakamura, Shin-ichi Ando, Seiya Kato, Toshiaki Kadokami
Internal Medicine.2022; 61(15): 2307. CrossRef
Clinically Suspected Myocarditis Temporally Related to COVID-19 Vaccination in Adolescents and Young Adults: Suspected Myocarditis After COVID-19 Vaccination
Dongngan T. Truong, Audrey Dionne, Juan Carlos Muniz, Kimberly E. McHugh, Michael A. Portman, Linda M. Lambert, Deepika Thacker, Matthew D. Elias, Jennifer S. Li, Olga H. Toro-Salazar, Brett R. Anderson, Andrew M. Atz, C. Monique Bohun, M. Jay Campbell, M
Circulation.2022; 145(5): 345. CrossRef
Myocarditis following rAd26 and rAd5 vector‐based COVID‐19 vaccine: case report
Farah Naghashzadeh, Shadi Shafaghi, Atosa Dorudinia, Seyed Alireza Naji, Majid Marjani, Ahmad Amin, Arezoo Mohamadifar, Sima Noorali, Babak Sharif Kashani
ESC Heart Failure.2022; 9(2): 1483. CrossRef
Myocarditis following COVID-19 vaccination in adolescents and adults: a cumulative experience of 2021
Onyedika J. Ilonze, Maya E. Guglin
Heart Failure Reviews.2022; 27(6): 2033. CrossRef
Chest Pain and Suspected Myocarditis Related to COVID-19 Vaccination in Adolescents—A Case Series
Da-Eun Roh, Hyejin Na, Jung-Eun Kwon, Insu Choi, Yeo-Hyang Kim, Hwa-Jin Cho
Children.2022; 9(5): 693. CrossRef
Cardiac Adverse Events after Vaccination—A Systematic Review
Kanak Parmar, Sai Subramanyam, Gaspar Del Rio-Pertuz, Pooja Sethi, Erwin Argueta-Sosa
Vaccines.2022; 10(5): 700. CrossRef
A case of myocarditis after COVID-19 vaccination: incidental or consequential?
Leona S. Alizadeh, Vitali Koch, Ibrahim Yel, Leon D. Grünewald, Daniel Mathies, Simon Martin, Thomas J. Vogl, Dominic Rauschning, Christian Booz
Heliyon.2022; 8(6): e09537. CrossRef
COVID-19 Vaccination and the Rate of Immune and Autoimmune Adverse Events Following Immunization: Insights From a Narrative Literature Review
Naim Mahroum, Noy Lavine, Aviran Ohayon, Ravend Seida, Abdulkarim Alwani, Mahmoud Alrais, Magdi Zoubi, Nicola Luigi Bragazzi
Frontiers in Immunology.2022;[Epub] CrossRef
COVID-19 vaccination and carditis in children and adolescents: a systematic review and meta-analysis
Oscar Hou In Chou, Jonathan Mui, Cheuk To Chung, Danny Radford, Simon Ranjithkumar, Endurance Evbayekha, Ronald Nam, Levent Pay, Danish Iltaf Satti, Sebastian Garcia-Zamora, George Bazoukis, Göksel Çinier, Sharen Lee, Vassilios S. Vassiliou, Tong Liu, Gar
Clinical Research in Cardiology.2022; 111(10): 1161. CrossRef
Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990–2018
John R. Su, Michael M. McNeil, Kerry J. Welsh, Paige L. Marquez, Carmen Ng, Ming Yan, Maria V. Cano
Vaccine.2021; 39(5): 839. CrossRef
Sipuleucel‐T associated inflammatory cardiomyopathy: a case report and observations from a large pharmacovigilance database
Melissa Y.Y. Moey, Rahim A. Jiwani, Kotaro Takeda, Karyn Prenshaw, R. Wayne Kreeger, John Inzerillo, Darla K. Liles, C. Bogdan Marcu, Bénédicte Lebrun‐Vignes, D. Lynn Morris, Sivakumar Ardhanari, Joe‐Elie Salem
ESC Heart Failure.2021; 8(4): 3360. CrossRef
Myocarditis following COVID-19 vaccination
Elisabeth Albert, Gerard Aurigemma, Jason Saucedo, David S. Gerson
Radiology Case Reports.2021; 16(8): 2142. CrossRef
Myocarditis and Other Cardiovascular Complications of the mRNA-Based COVID-19 Vaccines
Mahesh K Vidula, Marietta Ambrose, Helene Glassberg, Neel Chokshi, Tiffany Chen, Victor A Ferrari, Yuchi Han
Cureus.2021;[Epub] CrossRef
Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination
Han W. Kim, Elizabeth R. Jenista, David C. Wendell, Clerio F. Azevedo, Michael J. Campbell, Stephen N. Darty, Michele A. Parker, Raymond J. Kim
JAMA Cardiology.2021; 6(10): 1196. CrossRef
Acute myocarditis following Comirnaty vaccination in a healthy man with previous SARS-CoV-2 infection
Anna Patrignani, Nicolò Schicchi, Francesca Calcagnoli, Elena Falchetti, Nino Ciampani, Giulio Argalia, Antonio Mariani
Radiology Case Reports.2021; 16(11): 3321. CrossRef
Myocarditis and pericarditis after vaccination for COVID‐19
Blake Hudson, Ryan Mantooth, Matthew DeLaney
Journal of the American College of Emergency Physicians Open.2021;[Epub] CrossRef
Myocarditis, Pericarditis and Cardiomyopathy After COVID-19 Vaccination
Salvatore Pepe, Ann T. Gregory, A. Robert Denniss
Heart, Lung and Circulation.2021; 30(10): 1425. CrossRef
Cardiac Manifestations of Multisystem Inflammatory Syndrome in Children (MIS-C) Following COVID-19
Eveline Y. Wu, M. Jay Campbell
Current Cardiology Reports.2021;[Epub] CrossRef
Hemodynamic Collapse After Influenza Vaccination: A Vaccine-Induced Fulminant Myocarditis?
Nobutaka Nagano, Toshiyuki Yano, Yugo Fujita, Masayuki Koyama, Ryo Hasegawa, Jun Nakata, Ryo Nishikawa, Naoto Murakami, Takefumi Fujito, Atsushi Mochizuki, Hidemichi Kouzu, Atsuko Muranaka, Nobuaki Kokubu, Tetsuji Miura
Canadian Journal of Cardiology.2020; 36(9): 1554.e5. CrossRef
Fatal influenza myocarditis with incessant ventricular tachycardia
Nidhi Saraiya, Supriya Singh, Marilou Corpuz
BMJ Case Reports.2019; 12(7): e228201. CrossRef

Cardiology
Catecholamine-Induced Cardiomyopathy associated with Neuroblastoma and Treated with Extracorporeal Membrane Oxygenation as a Bridge to Recovery: Junggu Yi, Si Oh Kim, Jun-mo Park, Sung-hye Byun, Hoon Jung, Seong Wook Hong; Korean J Crit Care Med. 2015;30(4):299-302. Published online November 30, 2015; DOI: https://doi.org/10.4266/kjccm.2015.30.4.299

4,971 View
89 Download
1 Crossref

Abstract PDF

Catecholamine-induced cardiomyopathy associated with neuroblastoma is rarely reported. We report a case of catecholamine-induced cardiomyopathy associated with neuroblastoma in a 33-month-old female that was treated with extracorporeal membrane oxygenation (ECMO). She was tentatively diagnosed with acute myocarditis and presented with hypertension. Because of rapid patient deterioration despite pharmacological treatments, ECMO was applied. ECMO can be helpful in cases of catecholamine-induced cardiomyopathy associated with neuroblastoma.

Citations

Citations to this article as recorded by

COVID-19 and cardiovascular disease: manifestations, pathophysiology, vaccination, and long-term implication
Adel Abdel Moneim, Marwa A. Radwan, Ahmed I. Yousef
Current Medical Research and Opinion.2022; 38(7): 1071. CrossRef

Cardiology
Life-Threatening Acute Fulminant Myocarditis Following a Coffee Diet Program: Jung Hyun Kim, Hee Kyung Kim, Kyu Hyun Han, Bo Hye Kim, Hak Su Kim, Sun Young Shin, Eun Kyung Kim, Hye Cheol Jeong, Ji Hyun Lee; Korean J Crit Care Med. 2014;29(2):119-122. Published online May 31, 2014; DOI: https://doi.org/10.4266/kjccm.2014.29.2.119

8,441 View
45 Download

Abstract PDF: Myocarditis is an inflammatory disease of the myocardium caused by various infectious or noninfectious triggers. Although viral infections are important causes of myocarditis, some drugs or toxins can also cause myocarditis. We report a case of life-threatening fulminant myocarditis which followed an extensive coffee diet program. Despite medical treatment, the patient was not able to maintain hemodynamic stability. She was supported by extracorporeal membrane oxygenation and completely recovered 3 months later.

Cerebral Ischemic Stroke in an Infant with Acute Myocarditis: A Case Report: Ga Hyun Lee, Yeo Hyang Kim; Korean J Crit Care Med. 2013;28(2):119-122.; DOI: https://doi.org/10.4266/kjccm.2013.28.2.119

2,638 View
23 Download

Abstract PDF: A 9-month-old infant presented with cough, tachypnea, and grunting was admitted. The patient was revealed to have cardiomegaly, high NT-proBNP, and severe left ventricular dilation and dysfunction; she was subsequently diagnosed with acute myocarditis and congestive heart failure. Intravenous immunoglobulin, inotropics, diuretics, angiotensin converting enzyme inhibitors and beta blocker were used. However, left hemiparesis suddenly developed at 30-day after treatment. Brain MRI showed high signal intensity in the right middle cerebral arterial territory on diffusion weighted brain MRI and in the left parietal lobe with gyral enhancement. Echocardiogram revealed no definite intraventricular thrombus. The patient was started on an antiplatelet agent only without anticoagulant therapy for the treatment of cerebral infarct in respect of the risk to the infant. Four years after the cerebral ischemic stroke (CIS), she showed complete recovery from hemiparesis, with no more CIS. In conclusion, severe ventricular dilatation and dysfunction can lead to thromboembolic events in infants. We should keep in mind that anticoagulant or antiplatelet agents can be used in specific situations.

Successful Empirical Treatment of Intravenous Immune Globulin in Recent-Onset Idiopathic Dilated Cardiomyopathy: A Case Report: Hyun Soo Kim, Keum Nam Rim, Hyun Jong Shin, Sang Pyo Lee, Sang Bong Ahn, Yong Gu Lee, Young Chul Lee, Na Rae Ha, Sun Joo Chang, Jin Ho Shin; Korean J Crit Care Med. 2007;22(2):96-100.

1,651 View
32 Download

Abstract PDF: Intravenous immunoglobulin (IVIG) therapy has been introduced to idiopathic dilated cardiomyopathy due to their antiviral and anti-inflammatory effects. But each study reported conflicting result and treatment regimen has not been clearly established. We experienced a case of 28-year-old woman with idiopathic dilated cardiomyopathy with severely depressed cardiac function. Its onset time was obvious within 1 month. Despite of conservative treatment of heart failure, sudden cardiac arrest was developed. We tried IVIG therapy, and her symptoms and cardiac function were improved after IVIG treatment.

First
Prev
Page of 1
Next
Last

Search